Skip to main content
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology logoLink to Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
. 2022 Jul 23;18:65. doi: 10.1186/s13223-022-00705-y

Correction to: Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochloride

Ignacio J Ansotegui 1,, Jonathan A Bernstein 2, Giorgio W Canonica 3,9, Sandra N Gonzalez-Diaz 4, Bryan L Martin 5, Mario Morais-Almeida 6, Margarita Murrieta-Aguttes 7, Mario Sanchez Borges 8
PMCID: PMC9308920  PMID: 35870997

Correction to: Allergy, Asthma & Clinical Immunology (2022) 18:41 https://doi.org/10.1186/s13223-022-00677-z

In this article [1], the affiliation 'Department of Biomedical Sciences—Humanitas University—Pieve Emanuele (MI), Italy' for Giorgio W. Canonica was missing. It has been corrected with this correction.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Mario A. Sanchez Borges—Deceased

Reference

  • 1.Ansotegui IJ, Bernstein JA, Canonica GW, Gonzalez-Diaz SN, Martin BL, Morais-Almeida M, Murrieta-Aguttes M, Sanchez Borges M. Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochloride. Allergy Asthma Clin Immunol. 2022;18:41. doi: 10.1186/s13223-022-00677-z. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology are provided here courtesy of BMC

RESOURCES